A Member of the University of Maryland Medical System | In Partnership with the University of Maryland School of Medicine
Segmental glomerulosclerosis; Focal sclerosis with hyalinosis
Some patients will receive high doses of corticosteroids or a drug called cyclosporine to suppress their immune system.
The goal of treatment is to control the symptoms of nephrotic syndrome and prevent chronic kidney failure.
See also:
In general, treatments may include:
See also: Kidney disease - diet
More than half of those with focal or segmental glomerulosclerosis develop chronic kidney failure within 10 years.
You should call your doctor if you develop symptoms of this condition, especially if there is fever, pain with urination, or decreased urine output.
Appel GB. Glomerular disorders and nephrotic syndromes. In: Goldman L, Ausiello D, eds. Cecil Medicine. 23rd ed. Philadelphia, Pa: Saunders Elsevier; 2007:chap 122.
Nachman PH, Jennette JC, Falk, RJ. Primary glomerular disease. In: Brenner BM, ed. Brenner and Rector's The Kidney. 8th ed. Philadelphia, Pa: Saunders Elsevier; 2007:chap 30.
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).
© 2011 University of Maryland Medical Center (UMMC). All rights reserved.
UMMC is a member of the University of Maryland Medical System,
22 S. Greene Street, Baltimore, MD 21201. TDD: 1-800-735-2258 or 1.866.408.6885